EUVIMEDEUVIMED entdecken
Crossref

Immunogenic PANoptosis‐Initiated Cancer Sono‐Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle

Liqiang Zhou iD, Jinxiao Lyu, Fang Liu, Yanhong Su, Ling Feng, Xuanjun Zhang iD

Advanced Materials · 2024-01 · 36 (2)

DOI: 10.1002/adma.202305361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 23.11.2023. Verfasst von Liqiang Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Macau, Macau SAR, 999078, P. R. China. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 98-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Research Grant of University of Macau, Ministry of Education Frontiers Science Centre for Precision Oncology, University of Macau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cancer‐immune cycle conceptualized the mechanisms of driving T cell responses to tumors, but w as limited by immunological ignorance elicited by tumor inherent immunoediting, which failed to initiate and maintain adaptive immunity. Targeting specific vulnerabilities of cell death patterns may provide unique opportunities to boost T cell antitumor immunological effects. Here an ultrasound nanomedicine‐triggered tumor immuno‐reediting therapeutic strategy using nano/genetically engineered extracellular vesicles, which can induce tumor highly immunogenic PANoptosis and iteratively start‐up the energization of cancer innate immunity cycle by repeatedly liberating damage‐associated molecular patterns, thereby priming sufficient antigen‐specific T cells and shaping protective immune response through activating cGAS‐STING signaling pathways, is reported. Aided by immune checkpoint blockade, the reprogramming of immune microenvironment further facilitated a prompt bridging of innate and adaptive immunity, and remarkably suppressed metastatic and rechallenged tumor growth. Thus, targeting PANoptotic cell death provides a catcher against immune escape and a positive‐feedback immune activation gateway for overcoming immune resistance to intractable cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansT-LymphocytesImmunity, InnateAdaptive ImmunityAntigens, NeoplasmTumor MicroenvironmentImmunotherapy

Stichwörter der Autor:innen

PANoptosisengineered extracellular vesiclesimmune regulationregulated cell deathultrasound immune-reediting

Substanzen

Antigens, Neoplasm

Autor:innen und Institutionen

  • Faculty of Health Sciences, University of Macau, Macau SAR, 999078, P. R. China.
  • MOE Frontiers Science Center for Precision Oncology, University of Macau, Macau SAR, 999078, P. R. China.

ORCID-Profile: Liqiang Zhou, Xuanjun Zhang

Förderung

  • Research Grant of University of Macau
  • Ministry of Education Frontiers Science Centre for Precision Oncology
  • University of Macau
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia
  • National Nature Science Foundation of China
  • Universidade de Macau

Zitieren

APA

Zhou, L., Lyu, J., Liu, F., Su, Y., Feng, L., & Zhang, X. (2024). Immunogenic PANoptosis‐Initiated Cancer Sono‐Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle. Advanced Materials, 36(2). https://doi.org/10.1002/adma.202305361

Vancouver

Zhou L, Lyu J, Liu F, Su Y, Feng L, Zhang X. Immunogenic PANoptosis‐Initiated Cancer Sono‐Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle. Advanced Materials. 2024;36(2). doi:10.1002/adma.202305361

BibTeX
@article{Zhou2024,
  author = {Zhou, Liqiang and Lyu, Jinxiao and Liu, Fang and Su, Yanhong and Feng, Ling and Zhang, Xuanjun},
  title = {Immunogenic PANoptosis‐Initiated Cancer Sono‐Immune Reediting Nanotherapy by Iteratively Boosting Cancer Immunity Cycle},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {2},
  doi = {10.1002/adma.202305361}
}
Kostenlos starten →